1. Home
  2. Labeler Index
  3. A-s Medication Solutions
  4. 50090-3617
  5. Product Images: Pradaxa

Product Images Pradaxa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Pradaxa NDC 50090-3617 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Image - lbl500903617

Label Image - lbl500903617

Figure 1 - pradaxa 01

Figure 1 - pradaxa 01

This is a clinical trial report that compares the safety of Pradaxa 150 with warfarin for the prevention of major bleeding events in patients with stroke or cardiovascular risk factors. The trial involved over 18,000 patients who were divided into subgroups based on age, gender, weight, medical history, and other factors. The report includes statistical analyses, such as hazard ratios, for each subgroup to determine the efficacy of the treatments.*

Chemical Structure - pradaxa 02

Chemical Structure - pradaxa 02

Figure 2 - pradaxa 03

Figure 2 - pradaxa 03

This appears to be a chart or graph displaying the time course of a test called aPTT (activated partial thromboplastin time) with measurements in seconds. There are two dosages of a medication called PRADAXA listed, 150 mg BID (twice a day) for patients with a creatinine clearance > 30 mL/min and 75 mg BID for patients with a creatinine clearance € 30 mL/min. However, the chart is incomplete and it is unclear what the percentages indicate.*

Figure 3.1 - pradaxa 04

Figure 3.1 - pradaxa 04

Figure 3.2 - pradaxa 05

Figure 3.2 - pradaxa 05

This appears to be a table or chart without any clear headings. Without additional context or information, it is not possible to provide a useful description.*

Figure 4 - pradaxa 06

Figure 4 - pradaxa 06

This appears to be a graph or chart, but it cannot be properly read without additional context. The text includes medication names and dosages, as well as a time period, but the purpose or meaning of the chart is not available.*

Figure 5 - pradaxa 07

Figure 5 - pradaxa 07

This is a table of patient characteristics and their subgroups in a study comparing Pradaxa 150 to Warfarin for stroke. It provides information on patients' VKA use, age, gender, weight, history of stroke/TIA, diabetes at baseline, CHADS2 score, region, and ASA use at baseline. It also includes data on the number of patients in each subgroup and their respective total count. There are further columns and tables providing hazard ratios and confidence intervals for PRADAXA 150 vs. Warfarin.*

Figure - pradaxa 08

Figure - pradaxa 08

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.